Latigo Biotherapeutics Inc. (LTGO) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Latigo Biotherapeutics Inc. (LTGO) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $842.1M, listed on NASDAQ, employing roughly 66 people, carrying a beta of 0.00 to the broader market. Latigo Biotherapeutics, Inc. Led by Nima Farzan, public since 2026-08-07.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for LTGO as of 2026-10-15; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →